These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17596332)

  • 1. Initial therapy for suppurative microbial keratitis in Iraq.
    Al-Shakarchi F
    Br J Ophthalmol; 2007 Dec; 91(12):1583-7. PubMed ID: 17596332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy.
    Sharma V; Sharma S; Garg P; Rao GN
    Indian J Ophthalmol; 2004 Dec; 52(4):287-92. PubMed ID: 15693319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin-resistant Pseudomonas keratitis.
    Garg P; Sharma S; Rao GN
    Ophthalmology; 1999 Jul; 106(7):1319-23. PubMed ID: 10406614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group.
    Ophthalmology; 1997 Nov; 104(11):1902-9. PubMed ID: 9373124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the first contact management profile of cases of infectious keratitis: a hospital-based study.
    Vajpayee RB; Dada T; Saxena R; Vajpayee M; Taylor HR; Venkatesh P; Sharma N
    Cornea; 2000 Jan; 19(1):52-6. PubMed ID: 10632009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causative organisms in microbial keratitis, their sensitivity pattern and treatment outcome in western Nepal.
    Dhakhwa K; Sharma MK; Bajimaya S; Dwivedi AK; Rai S
    Nepal J Ophthalmol; 2012; 4(1):119-27. PubMed ID: 22344009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and causative organisms in microbial keratitis.
    Green M; Apel A; Stapleton F
    Cornea; 2008 Jan; 27(1):22-7. PubMed ID: 18245962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retrospective study of suppurative keratitis in 1054 patients].
    Zhong WX; Sun SY; Zhao J; Shi WY; Xie LX
    Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):245-50. PubMed ID: 17605908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of ciprofloxacin ophthalmic solution in the treatment of refractory bacterial keratitis.
    Tsai AC; Tseng MC; Chang SW; Hu FR
    J Formos Med Assoc; 1995 Dec; 94(12):760-4. PubMed ID: 8541741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
    Moreau JM; Green LC; Engel LS; Hill JM; O'Callaghan RJ
    Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
    Oguz H; Ozbilge H; Oguz E; Gurkan T
    Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial keratitis after manual descemet stripping endothelial keratoplasty--a different pathophysiology?
    Sengupta J; Khetan A; Saha S; Ganguly A; Pal D
    Eye Contact Lens; 2010 Jan; 36(1):62-5. PubMed ID: 19935426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis.
    Engel LS; Callegan MC; Hill JM; Folkens AT; Shimomura Y; O'Callaghan RJ
    Jpn J Ophthalmol; 1996; 40(2):212-9. PubMed ID: 8876389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance.
    Kunimoto DY; Sharma S; Garg P; Rao GN
    Ophthalmology; 1999 Jan; 106(1):80-5. PubMed ID: 9917785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-viral microbial keratitis: etiology, clinical features and visual outcome.
    Hussain I; Khan BS; Soni M; Iqbal M; Habibullah
    J Coll Physicians Surg Pak; 2012 Mar; 22(3):151-4. PubMed ID: 22414354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of propolis in the treatment of experimental Staphylococcus aureus keratitis in rabbits.
    Oksuz H; Duran N; Tamer C; Cetin M; Silici S
    Ophthalmic Res; 2005; 37(6):328-34. PubMed ID: 16138004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial keratitis after LASIK.
    Garg P; Chaurasia S; Vaddavalli PK; Muralidhar R; Mittal V; Gopinathan U
    J Refract Surg; 2010 Mar; 26(3):209-16. PubMed ID: 20229954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial susceptibility patterns for microbial isolates associated with infectious keratitis in horses: 63 cases (1986-1994).
    Moore CP; Collins BK; Fales WH
    J Am Vet Med Assoc; 1995 Oct; 207(7):928-33. PubMed ID: 7559027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late microbial keratitis after corneal transplantation.
    Tseng SH; Ling KC
    Cornea; 1995 Nov; 14(6):591-4. PubMed ID: 8575180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.